Tela Bio Inc (TELA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,273 | -38,831 | -29,790 | -21,187 | -11,264 |
| Depreciation Amortization | 264 | 1,010 | 785 | 537 | 267 |
| Income taxes - deferred | 60 | 230 | 85 | 85 | 52 |
| Accounts receivable | 593 | -110 | -1,042 | -935 | -402 |
| Accounts payable and accrued liabilities | 1,593 | 141 | 204 | -448 | 1,853 |
| Other Working Capital | -293 | 4,159 | 2,217 | 646 | 25 |
| Other Operating Activity | -1,114 | 5,182 | 4,192 | 3,672 | -256 |
| Operating Cash Flow | $-11,170 | $-28,219 | $-23,349 | $-17,630 | $-9,725 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -119 | -448 | -357 | -146 | -32 |
| Net Acquisitions | 309 | 1,294 | 1,011 | 488 | 170 |
| Investing Cash Flow | $190 | $846 | $654 | $342 | $138 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 60,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -42,420 | N/A | N/A | N/A |
| Common Stock Issued | 28 | 11,929 | 106 | 61 | 61 |
| Other Financing Activity | -326 | -3,759 | -201 | -180 | -177 |
| Financing Cash Flow | $-298 | $25,750 | $-95 | $-119 | $-116 |
| Exchange Rate Effect | -26 | -217 | -182 | -286 | -134 |
| Beginning Cash Position | 51,095 | 52,935 | 52,935 | 52,935 | 52,935 |
| End Cash Position | 39,791 | 51,095 | 29,963 | 35,242 | 43,098 |
| Net Cash Flow | $-11,304 | $-1,840 | $-22,972 | $-17,693 | $-9,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,170 | -28,219 | -23,349 | -17,630 | -9,725 |
| Capital Expenditure | -119 | -448 | -357 | -146 | -32 |
| Free Cash Flow | -11,289 | -28,667 | -23,706 | -17,776 | -9,757 |